View in EDS HTML Full Text PDF Full Text

Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment.

Saved in:
Bibliographic Details
Title: Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment.
Authors: Altıntaş YE; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye., Kınıkoğlu O; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye., Işık D; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye., Güneş TK; Department of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34760, Türkiye., Özkerim U; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye., Basoglu T; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye., Sürmeli H; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye., Odabaş H; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye., Turan N; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.
Source: Cancers [Cancers (Basel)] 2025 Mar 23; Vol. 17 (7). Date of Electronic Publication: 2025 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40227569
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Altıntaş+YE%22">Altıntaş YE</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.<br /><searchLink fieldCode="AU" term="%22Kınıkoğlu+O%22">Kınıkoğlu O</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.<br /><searchLink fieldCode="AU" term="%22Işık+D%22">Işık D</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.<br /><searchLink fieldCode="AU" term="%22Güneş+TK%22">Güneş TK</searchLink>; Department of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34760, Türkiye.<br /><searchLink fieldCode="AU" term="%22Özkerim+U%22">Özkerim U</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.<br /><searchLink fieldCode="AU" term="%22Basoglu+T%22">Basoglu T</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.<br /><searchLink fieldCode="AU" term="%22Sürmeli+H%22">Sürmeli H</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.<br /><searchLink fieldCode="AU" term="%22Odabaş+H%22">Odabaş H</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.<br /><searchLink fieldCode="AU" term="%22Turan+N%22">Turan N</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2025 Mar 23; Vol. 17 (7). <i>Date of Electronic Publication: </i>2025 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40227569
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers17071076
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Altıntaş YE
      – PersonEntity:
          Name:
            NameFull: Kınıkoğlu O
      – PersonEntity:
          Name:
            NameFull: Işık D
      – PersonEntity:
          Name:
            NameFull: Güneş TK
      – PersonEntity:
          Name:
            NameFull: Özkerim U
      – PersonEntity:
          Name:
            NameFull: Basoglu T
      – PersonEntity:
          Name:
            NameFull: Sürmeli H
      – PersonEntity:
          Name:
            NameFull: Odabaş H
      – PersonEntity:
          Name:
            NameFull: Turan N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 03
              Text: 2025 Mar 23
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1